All-Cause Mortality in People with Co-Occurring Insomnia Symptoms and Sleep Apnea: Analysis of the Wisconsin Sleep Cohort
Bastien Lechat,Kelly A Loffler,Douglas M Wallace,Amy Reynolds,Sarah L Appleton,Hannah Scott,Andrew Vakulin,Nicole Lovato,Robert Adams,Danny J Eckert,Peter G Catcheside,Alexander Sweetman
DOI: https://doi.org/10.2147/NSS.S379252
2022-10-13
Nature and Science of Sleep
Abstract:Bastien Lechat, 1 Kelly A Loffler, 1 Douglas M Wallace, 2, 3 Amy Reynolds, 1 Sarah L Appleton, 1 Hannah Scott, 1 Andrew Vakulin, 1, 4 Nicole Lovato, 1, 4 Robert Adams, 1, 4 Danny J Eckert, 1 Peter G Catcheside, 1 Alexander Sweetman 1, 4 1 Adelaide Institute for Sleep Health and FHMRI Sleep Health, Flinders University, Adelaide, South Australia, Australia; 2 Department of Neurology, Sleep Medicine Division, University of Miami Miller School of Medicine, Miami, FL, USA; 3 Neurology Service, Bruce W. Carter Department of Veterans Affairs Medical Centre, Miami, FL, USA; 4 National Centre for Sleep Health Services Research: A NHMRC Centre of Research Excellence, Flinders University, Adelaide, South Australia, Australia Correspondence: Bastien Lechat, Adelaide Institute for Sleep Health and Flinders Health and Medical Research Institute: Sleep Health, Level 2A, Mark Oliphant Building, 5 Laffer Drive, Flinders University, Bedford Park, South Australia, 5042, Australia, Email Purpose: Insomnia symptoms and sleep apnea frequently co-occur and are associated with worse sleep, daytime function, mental health and quality of life, compared to either insomnia or obstructive sleep apnea (OSA) alone. This study aimed to investigate the association of symptoms of co-morbid insomnia and sleep apnea (COMISA) with all-cause mortality. Patients and Methods: Wisconsin Sleep Cohort data were analysed to assess potential associations between COMISA symptoms and all-cause mortality. Nocturnal insomnia symptoms were defined as difficulties initiating sleep, maintaining sleep, and/or early morning awakenings "often" or "almost always", and/or regular sedative-hypnotic medicine use. OSA was defined as an apnea-hypopnea index ≥ 5/hr sleep. Participants were classified as having neither insomnia symptoms nor OSA, insomnia symptoms alone, OSA alone, or COMISA symptoms. Associations between the four groups and all-cause mortality over 20 years of follow-up were examined via multivariable adjusted Cox regression models. Results: Among 1115 adult participants (mean ± SD age 55 ± 8 years, 53% males), 19.1% had COMISA symptoms. After controlling for sociodemographic and behavioral factors, COMISA symptoms were associated with an increased risk of all-cause mortality compared to no insomnia symptoms or OSA (HR [95% CI]; 1.71 [1.00– 2.93]). OSA alone (0.91 [0.53, 1.57]) and insomnia symptoms alone (1.04 [0.55, 1.97]) were not associated with increased mortality risk. Conclusion: Co-morbid insomnia symptoms and sleep apnea is associated with increased all-cause mortality risk. Future research should investigate mechanisms underpinning COMISA and the effectiveness of different treatment approaches to reduce mortality risk for this common condition. Keywords: sleep disordered breathing, Wisconsin Sleep Cohort, COMISA, obstructive, sleep apnea, insomnia, respiratory The co-occurrence of insomnia symptoms in people with obstructive sleep apnea (COMISA) is highly prevalent and is associated with poorer cardio-metabolic and mental health. This study investigated the association between COMISA and all-cause mortality over a 19-year follow-up in 1115 adult participants (number of deaths: 108). COMISA was associated with poorer cardiovascular and metabolic health at baseline, with higher prevalence of cardiovascular diseases, hypertension and diabetes compared to participants with neither sleep disorder. Participants with COMISA also had more depression and anxiety symptoms than participants with no sleep disorders. COMISA was also associated with a ~70% increased risk in all-cause mortality compared to control; further suggesting that people with insomnia symptoms and obstructive sleep apnea may be a specific group at higher risk of poor health. Obstructive sleep apnea (OSA) and insomnia are the two most common clinical sleep disorders, and frequently co-occur. 1–3 OSA is characterized by brief closure (apnea) and narrowing (hypopnea) of the upper airway during sleep, which results in frequent cortical arousals from sleep, non-restorative sleep, worse physical/mental health, and reduced quality of life. 2,4,5 It is estimated that 20% of people worldwide have OSA. 6 Insomnia is characterized by difficulties initiating sleep, maintaining sleep or early morning awakenings from sleep, which results in daytime impairment. 2 Approximately 25–50% of the general adult population report infrequent or acute insomnia symptoms, and 6–20% experience chronic insomnia disorder (symptoms persisting for ≥ 3 months). 7–11 Co-morb -Abstract Truncated-
neurosciences,clinical neurology